-transparent.png){kind=logo}
We studied the prevalence of hypophosphataemia (< 0.80 mmol/l) in seventeen patients who had undergone bone marrow transplantation (BMT). Thirteen (77%) of the seventeen patients had hypophosphataemia at some stage during the conditioning phase or after their BMT. Seven (41%) of the seventeen patients had hypophosphataemia in the peri-BMT period that is during the conditioning phase or within one week thereafter. Two of the patients showed severe hypophosphataemia (< 0.30 mmol/l). We suggest that plasma phosphate should be monitored in patients with a bone marrow transplant.
Related Publications
M Crook, and
R Swaminathan, and
S Schey
April 1996,
British journal of haematology,
M Crook, and
R Swaminathan, and
S Schey
March 1983,
Human pathology,
M Crook, and
R Swaminathan, and
S Schey
January 1984,
Medical and pediatric oncology,
M Crook, and
R Swaminathan, and
S Schey
April 1994,
The Annals of otology, rhinology, and laryngology,
M Crook, and
R Swaminathan, and
S Schey
July 1997,
The European journal of surgery = Acta chirurgica,
M Crook, and
R Swaminathan, and
S Schey
September 1987,
Cancer,
M Crook, and
R Swaminathan, and
S Schey
November 1985,
Oral surgery, oral medicine, and oral pathology,
M Crook, and
R Swaminathan, and
S Schey
February 1985,
The New England journal of medicine,
M Crook, and
R Swaminathan, and
S Schey
February 1981,
Haematologica,
M Crook, and
R Swaminathan, and
S Schey
January 1994,
Progress in clinical and biological research,
